Medical devices industry M&A deals in September 2020 total $9.86bn globally
Total medical devices industry M&A deals in September 2020 worth $9.86bn were announced globally, according to GlobalData's deals database. Embed...
-
DialityCapital Raising$12.5M
-
KatenaMergers & AcquisitionsUndisclosed
-
NeuromodMergers & Acquisitions$12.4M
-
Astellas PharmaMergers & Acquisitions$429M
-
BroncusCapital RaisingUndisclosed
-
Avail MedsystemsCapital Raising$100M
-
Intersect ENTMergers & Acquisitions$60M
-
MedtronicMergers & AcquisitionsUndisclosed
-
Cardiac DimensionsCapital Raising$17.5M
-
Smith+NephewMergers & Acquisitions$240M
-
Swiss Medical GroupMergers & AcquisitionsUndisclosed
-
Salvia BioElectronicsCapital Raising$30M
-
Medasense BiometricsCapital Raising$18M
-
V-WaveCapital Raising$98M
-
BioProtectCapital Raising$25M
-
IlluminaMergers & Acquisitions$8BN
-
RapidAICapital Raising$25M
-
TakedaMergers & Acquisitions$350M
-
AidocCapital Raising$20M
-
MedigateCapital Raising$30M
-
Intersect ENTMergers & Acquisitions$60M
-
RLDatixnMergers & AcquisitionsUndisclosed
-
BrukerMergers & AcquisitionsUndisclosed
-
LightForce OrthodonticsCapital Raising$14M
-
Fukushima SiC Applied EngineeringCapital Raising$30M
-
MBL GroupMergers & AcquisitionsUndisclosed
-
InfosysMergers & Acquisitions$42M
-
CryoLifeMergers & Acquisitions$200M
-
MedGynMergers & AcquisitionsUndisclosed
-
ArchiMedMergers & AcquisitionsUndisclosed
-
![]()
Medical devices industry deals in September 2020 total $11.62bn globally
-
![]()
US medical devices industry sees a drop of 26.8% in deal activity in September 2020
-
![]()
Medical devices industry venture financing deals in September 2020 total $419.95m in US
-
![]()
Medical devices industry deals in August 2020 total $20.36bn globally
-
![]()
Medical devices industry venture financing deals in August 2020 total $1.47bn globally
-
![]()
Medical devices industry M&A deals in August 2020 total $17.17bn globally
Submit a deal
Ensure your company's deals are accurately presented to thousands of potential clients by using our deals submission form.
DEALS ANALYSIS
US medical devices industry sees a rise of 18.5% in deal activity in August 2020
The US medical devices industry saw a rise of 18.5% in overall deal activity during August 2020, when compared with the last 12-month average, according to GlobalData's deals database.
Medical devices industry venture financing deals in August 2020 total $1.03bn in US
Total medical devices industry venture financing deals in August 2020 worth $1.03bn were announced in the US, according to GlobalData's deals database.
Salvia Bioelectronics migraine therapy may offer alternative to drugs
Salvia Bioelectronics, a Dutch neurostimulation company targeting chronic migraines, has raised €26m from new and existing investors in a Series A funding round led by Panakès Partners, INKEF Capital and...
Medical devices industry deals in July 2020 total $4.15bn globally
Total medical devices industry deals for July 2020 worth $4.15bn were announced globally, according to GlobalData's deals database.
Medical devices industry venture financing deals in July 2020 total $1.8bn globally
Total medical devices industry venture financing deals in July 2020 worth $1.8bn were announced globally, according to GlobalData's deals database.
Medical devices industry M&A deals in July 2020 total $1.87bn globally
Total medical devices industry M&A deals in July 2020 worth $1.87bn were announced globally, according to GlobalData's deals database.
US medical devices industry sees a drop of 9.9% in deal activity in July 2020
The US medical devices industry saw a drop of 9.9% in overall deal activity during July 2020, when compared with the last 12-month average, according to GlobalData's deals database.
Medical devices industry venture financing deals in July 2020 total $1.2bn in US
Total medical devices industry venture financing deals in July 2020 worth $1.2bn were announced in the US, according to GlobalData's deals database.
Medtech looks towards recovery after tumultuous Q2 2020
Q2 2020 was, unsurprisingly, a financial quarter defined by Covid-19 – particularly so in the medical technology sector, an area of business situated well within the financial and economic blast...
Why did the Thermo Fisher-Qiagen deal fall apart?
On 13 August, Thermo Fisher Scientific announced that its bid to acquire diagnostic technology firm Qiagen had failed and the planned deal was terminated. The deal, which was made public...